36
Participants
Start Date
May 31, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
APR-246
Intravenous infusion. Dose escalating. Dosing will be conducted with three patients at each dose level.
Section of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg
Department of Hematology, University Hospital, Örebro
Urology clinic, University Hospital, Örebro
Clinical Research and Development Unit, Department of Oncology, Akademiska Hospital, Uppsala
Department of Haematology, Akademiska Hospital, Uppsala
Hematology Centre, M54, Karolinska Institute, Karolinska University Hospital, Huddinge, Stockholm
Lead Sponsor
Aprea Therapeutics
INDUSTRY